Other studies indicate that GBM-initiating cells (GIC), which display stem cell properties, are involved in tumor resistance to TMZ, and RSV has been shown to enhance GIC sensitivity to TMZ by activating the pATM/pATR/p53 pathway and promoting cancer cell apoptosis. This evidence concerns the gene TP53 and glioblastoma.